News

Filter

Current filters:

None

7928 to 7937 of 97511 results

Merck Serono gains rights to Ph II cancer drug from Symphogen for up to 475 million euros

06-09-2012

Privately-held Danish drug developer Symphogen A/S announced this morning that it has signed an exclusive…

BiotechnologyLicensingMerck KGaAMerck SeronoOncologyPharmaceuticalSym004Symphogen

FDA nod for Pfizer's rare leukemia drug Bosulif

06-09-2012

In a third cancer drug approval in just over a year for drugs behemoth Pfizer (NYSE: PFE), the US Food…

BosulifbosutinibNorth AmericaOncologyPfizerPharmaceuticalRare diseasesRegulation

Myrexis returns rights to Azixa to EpiCept

06-09-2012

US drug developer EpiCept (Nasdaq: EPCT) says it has received notice of termination, effective as of…

AzixaBiotechnologyEpiCeptLicensingMyrexisOncologyPharmaceutical

Safety of Novartis' Lucentis in VI-DME confirmed with new data; efficacy in CNV

06-09-2012

New data revealed yesterday by Swiss drug major Novartis (NOVN: VX) showed that Lucentis (ranibizumab)…

DiabetesLucentisNovartisOphthalmicsPharmaceuticalRegulationResearchRoche

Validity of certain patent claims covering Santarus' Zegerid capsule and powder upheld

06-09-2012

US drugmaker Santarus (Nasdaq: SNTS) saw its shares leap 14.2% to $7.06 in regular trading on September…

GenericsLegalNorth AmericaPar PharmaceuticalPatentsPharmaceuticalSantarusZegerid

Dainippon Sumitomo files for approval of Calsed in China

06-09-2012

Japanese drug major Dainippon Sumitomo Pharma (TYO: 4506) has submitted an imported drug registration…

Asia-PacificCalsedDainippon Sumitomo PharmaOncologyPharmaceuticalRegulation

FDA action on Salix' crofelemer delayed until 2013

05-09-2012

There was disappointing news for Salix Pharmaceuticals (Nasdaq: SLXP) with the Food and Drug Administration…

crofelemerGastro-intestinalsNorth AmericaPharmaceuticalRegulationSalix Pharmaceuticals

Most US and European physicians believe automatic substitution of biosimilars is a bad idea

05-09-2012

Specialist physicians surveyed in the USA and Europe are generally opposed to pharmacy-level automatic…

BiotechnologyDiabetesEuropeGenericsMarkets & MarketingNorth America

Almirall sets up first direct North America presence

05-09-2012

Almirall (ALM: MC), Spain's largest pharmaceutical company, says it has set up a new affiliate in Canada…

aclidiniumAlmirallMarkets & MarketingNorth AmericaPharmaceuticalRespiratory and Pulmonary

7928 to 7937 of 97511 results

Back to top